{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T05:04:20Z","timestamp":1782968660085,"version":"3.54.5"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,25]]},"DOI":"10.7759\/cureus.19906","type":"journal-article","created":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T05:05:18Z","timestamp":1637903118000},"source":"Crossref","is-referenced-by-count":1,"title":["Prolonged Methylprednisolone Therapy in the Fibro-Proliferative Phase of Acute Respiratory Distress Syndrome"],"prefix":"10.7759","author":[{"given":"Derya","family":"Kocakaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sehnaz","family":"Olgun Y\u0131ld\u0131zeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c7i\u011fdem","family":"Ataizi-\u00c7elikel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berrin","family":"Ceyhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.149.3.7509706","article-title":"The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination","volume":"149","author":"Bernard GR","year":"1994","unstructured":"Bernard GR, Artigas A, Brigham KL, et al.. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994, 149:818-24. 10.1164\/ajrccm.149.3.7509706","journal-title":"Am J Respir Crit Care Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.100.4.943","article-title":"Fibroproliferative phase of ARDS. Clinical findings and effects of corticosteroids","volume":"100","author":"Meduri GU","year":"1991","unstructured":"Meduri GU, Belenchia JM, Estes RJ, Wunderink RG, el Torky M, Leeper KV Jr. Fibroproliferative phase of ARDS. Clinical findings and effects of corticosteroids. Chest. 1991, 100:943-52. 10.1378\/chest.100.4.943","journal-title":"Chest"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200005043421806","article-title":"The acute respiratory distress syndrome","volume":"342","author":"Ware LB","year":"2000","unstructured":"Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000, 342:1334-49. 10.1056\/NEJM200005043421806","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1378\/chest.105.5.1516","article-title":"Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS. Patterns of response and predictors of outcome","volume":"105","author":"Meduri GU","year":"1994","unstructured":"Meduri GU, Chinn AJ, Leeper KV, et al.. Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS. Patterns of response and predictors of outcome. Chest. 1994, 105:1516-27. 10.1378\/chest.105.5.1516","journal-title":"Chest"},{"key":"ref5","article-title":"Are corticosteroids useful in late-stage acute respiratory distress syndrome?","volume":"55","author":"Sessler CN","year":"2010","unstructured":"Sessler CN, Gay PC. Are corticosteroids useful in late-stage acute respiratory distress syndrome? . Resp Care. 2010, 55:43-55.","journal-title":"Resp Care"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051693","article-title":"Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome","volume":"354","author":"Steinberg KP","year":"2006","unstructured":"Steinberg KP, Hudson LD, Goodman RB, et al.. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med. 2006, 354:1671-84. 10.1056\/NEJMoa051693","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.96.09122650","article-title":"The role of the host defence response in the progression and outcome of ARDS: pathophysiological correlations and response to glucocorticoid treatment","volume":"9","author":"Meduri GU","year":"1996","unstructured":"Meduri GU. The role of the host defence response in the progression and outcome of ARDS: pathophysiological correlations and response to glucocorticoid treatment. Eur Respir J. 1996, 9:2650-70. 10.1183\/09031936.96.09122650","journal-title":"Eur Respir J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-141-6-200409210-00012","article-title":"The acute respiratory distress syndrome","volume":"141","author":"Piantadosi CA","year":"2004","unstructured":"Piantadosi CA, Schwartz DA. The acute respiratory distress syndrome. Ann Intern Med. 2004, 141:460-70. 10.7326\/0003-4819-141-6-200409210-00012","journal-title":"Ann Intern Med"},{"key":"ref9","article-title":"Pathologic features and mechanisms of hypoxemia in adult respiratory distress syndrome","volume":"114","author":"Lamy M","year":"1976","unstructured":"Lamy M, Fallat RJ, Koeniger E, et al.. Pathologic features and mechanisms of hypoxemia in adult respiratory distress syndrome. Am Rev Respir Dis. 1976, 114:267-84.","journal-title":"Am Rev Respir Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.2.159","article-title":"Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial","volume":"280","author":"Meduri GU","year":"1998","unstructured":"Meduri GU, Headley AS, Golden E, Carson SJ, Umberger RA, Kelso T, Tolley EA. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA. 1998, 280:159-65. 10.1001\/jama.280.2.159","journal-title":"JAMA"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1378\/chest.07-0714","article-title":"Corticosteroids in ARDS: a counterpoint","volume":"132","author":"Meduri GU","year":"2007","unstructured":"Meduri GU, Marik PE, Pastores SM, Annane D. Corticosteroids in ARDS: a counterpoint. Chest. 2007, 132:1093-4. 10.1378\/chest.07-0714","journal-title":"Chest"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.165.7.2106014","article-title":"Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids","volume":"165","author":"Meduri GU","year":"2002","unstructured":"Meduri GU, Tolley EA, Chrousos GP, Stentz F. Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids. Am J Respir Crit Care Med. 2002, 165:983-91. 10.1164\/ajrccm.165.7.2106014","journal-title":"Am J Respir Crit Care Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200302-256OC","article-title":"Effect of corticosteroid on lung parenchyma remodeling at an early phase of acute lung injury","volume":"168","author":"Rocco PR","year":"2003","unstructured":"Rocco PR, Souza AB, Faffe DS, et al.. Effect of corticosteroid on lung parenchyma remodeling at an early phase of acute lung injury. Am J Respir Crit Care Med. 2003, 168:677-84. 10.1164\/rccm.200302-256OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1985.01390290012002","article-title":"Idiopathic pulmonary fibrosis in adult respiratory distress syndrome. Diagnosis and treatment","volume":"120","author":"Ashbaugh DG","year":"1985","unstructured":"Ashbaugh DG, Maier RV. Idiopathic pulmonary fibrosis in adult respiratory distress syndrome. Diagnosis and treatment. Arch Surg. 1985, 120:530-5. 10.1001\/archsurg.1985.01390290012002","journal-title":"Arch Surg"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1378\/chest.97.1.138","article-title":"Established ARDS treated with a sustained course of adrenocortical steroids","volume":"97","author":"Hooper RG","year":"1990","unstructured":"Hooper RG, Kearl RA. Established ARDS treated with a sustained course of adrenocortical steroids. Chest. 1990, 97:138-43. 10.1378\/chest.97.1.138","journal-title":"Chest"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2009.08.009","article-title":"Corticosteroid therapy for acute lung injury, acute respiratory distress syndrome, and severe pneumonia: a meta-analysis of randomized controlled trials","volume":"25","author":"Lamontagne F","year":"2010","unstructured":"Lamontagne F, Briel M, Guyatt GH, Cook DJ, Bhatnagar N, Meade M. Corticosteroid therapy for acute lung injury, acute respiratory distress syndrome, and severe pneumonia: a meta-analysis of randomized controlled trials. J Crit Care. 2010, 25:420-35. 10.1016\/j.jcrc.2009.08.009","journal-title":"J Crit Care"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2007.01060.x","article-title":"Do glucocorticoids decrease mortality in acute respiratory distress syndrome? A meta-analysis","volume":"12","author":"Agarwal R","year":"2007","unstructured":"Agarwal R, Nath A, Aggarwal AN, Gupta D. Do glucocorticoids decrease mortality in acute respiratory distress syndrome? A meta-analysis. Respirology. 2007, 12:585-90. 10.1111\/j.1440-1843.2007.01060.x","journal-title":"Respirology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31819fb507","article-title":"Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis","volume":"37","author":"Tang BM","year":"2009","unstructured":"Tang BM, Craig JC, Eslick GD, Seppelt I, McLean AS. Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care Med. 2009, 37:1594-603. 10.1097\/CCM.0b013e31819fb507","journal-title":"Crit Care Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-015-4095-4","article-title":"Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients' data from four randomized trials and trial-level meta-analysis of the updated literature","volume":"42","author":"Meduri GU","year":"2016","unstructured":"Meduri GU, Bridges L, Shih MC, Marik PE, Siemieniuk RA, Kocak M. Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients' data from four randomized trials and trial-level meta-analysis of the updated literature. Intensive Care Med. 2016, 42:829-40. 10.1007\/s00134-015-4095-4","journal-title":"Intensive Care Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/45113-prolonged-methylprednisolone-therapy-in-the-fibro-proliferative-phase-of-acute-respiratory-distress-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:31:29Z","timestamp":1707507089000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/45113-prolonged-methylprednisolone-therapy-in-the-fibro-proliferative-phase-of-acute-respiratory-distress-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,25]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.19906","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,25]]}}}